Approval Overview and Clinical Evaluation Considerations of Companion Diagnostic Reagents for Antineoplastic Drugs Based on Next Generation Sequencing Technology

Fang Li, Lin Yuanyuan, Liu Rongzhi, Xu Chao, He Jingyun

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (5) : 529-534.

PDF(930 KB)
PDF(930 KB)
Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (5) : 529-534. DOI: 10.16153/j.1002-7777.2026-02-0033
Supervision & Administration: Special Column on Quality Control Research of In Vitro Diagnostic Reagents

Approval Overview and Clinical Evaluation Considerations of Companion Diagnostic Reagents for Antineoplastic Drugs Based on Next Generation Sequencing Technology

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 40(5): 529-534 https://doi.org/10.16153/j.1002-7777.2026-02-0033

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(930 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉